Ignacio
Melero Bermejo
Catedrático de Universidad
Icahn School of Medicine at Mount Sinai
Nueva York, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von Icahn School of Medicine at Mount Sinai (10)
2024
-
Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease
Journal for ImmunoTherapy of Cancer, Vol. 12, Núm. 4
2022
-
Cancer vaccines: the next immunotherapy frontier
Nature Cancer, Vol. 3, Núm. 8, pp. 911-926
-
Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st–2nd, 2021
Journal of Translational Medicine, Vol. 20, Núm. 1
2021
-
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma
Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 9
2020
-
Repurposing the yellow fever vaccine for intratumoral immunotherapy
EMBO Molecular Medicine, Vol. 12, Núm. 1
2018
-
Starting the fight in the tumor: Expert recommendations for the development of human intratumoral immunotherapy (HIT-IT)
Annals of Oncology, Vol. 29, Núm. 11, pp. 2163-2174
2016
-
Perspectives in immunotherapy: Meeting report from the "Immunotherapy Bridge", Napoli, December 5th 2015
Journal for ImmunoTherapy of Cancer, Vol. 4, Núm. 1
2015
-
Consensus nomenclature for CD8+ T cell phenotypes in cancer
OncoImmunology, Vol. 4, Núm. 4
2014
-
Classification of current anticancer immunotherapies
Oncotarget, Vol. 5, Núm. 24, pp. 12472-12508
-
Future perspectives in melanoma research: Meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013
Journal of Translational Medicine, Vol. 12, Núm. 1